Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression

Journal of Biological Chemistry

Volumn 288, Issue 26, 2013, Pages 19288-19295

  Rohira, Aarti D ^a   Chen, Chun Yuan ^a   Allen, Justin R ^a   Johnson, Deborah L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHETIC CAPACITY; CANCER DEVELOPMENT; LYSINE RESIDUES; MAMMALIAN TARGET OF RAPAMYCIN (MTOR); ONCOGENIC TRANSFORMATION; SMALL UBIQUITIN-LIKE MODIFIERS; SUBCELLULAR LOCALIZATIONS; TRANSCRIPTIONAL REPRESSORS;

AMINO ACIDS; ANTIBIOTICS; GENES; RNA;

TRANSCRIPTION;

DNA DIRECTED RNA POLYMERASE III; LYSINE; MAF1 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN UBC9; REPRESSOR PROTEIN; SENTRIN SUMO SPECIFIC PROTEASE 1; SUMO 1 PROTEIN; SUMO 2 PROTEIN; TRANSFER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; COVALENT BOND; GENE REPRESSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUMOYLATION; TRANSCRIPTION REGULATION; TRNA GENE;

POST-TRANSLATIONAL MODIFICATION; RNA POLYMERASE III; TRANSCRIPTION FACTORS; TRANSCRIPTION REGULATION; TRANSCRIPTION REPRESSOR;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOPEPTIDASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LYSINE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; RNA POLYMERASE III; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 84879598945     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.473744     Document Type: Article

References (26)

1. Johnson, D. L., and Johnson, S. A. (2008) Cell biology. RNA metabolism and oncogenesis. Science 320, 461-462 (Pubitemid 351590655)
2. Johnson, S. A., Dubeau, L., and Johnson, D. L. (2008) Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation. J. Biol. Chem. 283, 19184-19191
3. Pluta, K., Lefebvre, O., Martin, N. C., Smagowicz, W. J., Stanford, D. R., Ellis, S. R., Hopper, A. K., Sentenac, A., and Boguta, M. (2001) Maf1p, a negative effector of RNA polymerase III in Saccharomyces cerevisiae. Mol. Cell Biol. 21, 5031-5040 (Pubitemid 32656400)
4. Upadhya, R., Lee, J., and Willis, I. (2002) Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription. Mol. Cell 10, 1489-1494 (Pubitemid 36050888)
5. Boguta, M. (2013) Maf1, a general negative regulator of RNA polymerase III in yeast. Biochim. Biophys. Acta 1829, 376-384
6. Johnson, S. S., Zhang, C., Fromm, J., Willis, I. M., and Johnson, D. L. (2007) Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol. Cell 26, 367-379 (Pubitemid 46687096)
7. Zhong, S., Fromm, J., and Johnson, D. L. (2007) TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation. Mol. Cell Biol. 27, 54-64 (Pubitemid 46013232)
8. Johnson, S. A., Dubeau, L., Kawalek, M., Dervan, A., Schönthal, A. H., Dang, C. V., and Johnson, D. L. (2003) Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. Mol. Cell Biol. 23, 3043-3051 (Pubitemid 36459220)
9. Hay, R. (2005) SUMO: a history of modification. Mol. Cell 18, 1-12
10. Müller, S., Ledl, A., and Schmidt, D. (2004) SUMO: a regulator of gene expression and genome integrity. Oncogene 23, 1998-2008
11. Kantidakis, T., Ramsbottom, B. A., Birch, J. L., Dowding, S. N., and White, R. J. (2010) mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc. Natl. Acad. Sci. U.S.A. 107, 11823-11828
12. Michels, A. A., Robitaille, A. M., Buczynski-Ruchonnet, D., Hodroj, W., Reina, J. H., Hall, M. N., and Hernandez, N. (2010) mTORC1 directly phosphorylates and regulates human MAF1. Mol. Cell Biol. 30, 3749-3757
13. Bawa-Khalfe, T., and Yeh, E. T. (2010) SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression. Genes Cancer 1, 748-752
14. Lin, X., Liang, M., Liang, Y. Y., Brunicardi, F. C., and Feng, X. H. (2003) SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem. 278, 31043-31048 (Pubitemid 36994618)
15. Li, X., Luo, Y., Yu, L., Lin, Y., Luo, D., Zhang, H., He, Y., Kim, Y. O., Kim, Y., Tang, S., and Min, W. (2008) SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis. Cell Death Differ. 15, 739-750 (Pubitemid 351405079)
16. Fromm, J. A., Johnson, S. A., and Johnson, D. L. (2008) Epidermal growth factor receptor 1 (EGFR1) and its variant EGFRvIII regulate TATA-binding protein expression through distinct pathways. Mol. Cell Biol. 28, 6483-6495
17. Gridasova, A. A., and Henry, R. W. (2005) The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specificDNAbinding. Mol. Cell Biol. 25, 3247-3260 (Pubitemid 40464325)
18. Shor, B., Wu, J., Shakey, Q., Toral-Barza, L., Shi, C., Follettie, M., and Yu, K. (2010) Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control ofRNApolymerase III-dependent transcription in cancer cells. J. Biol. Chem. 285, 15380-15392
19. Vannini, A., Ringel, R., Kusser, A. G., Berninghausen, O., Kassavetis, G. A., and Cramer, P. (2010) Molecular basis of RNA polymerase III transcription repression by Maf1. Cell 143, 59-70
20. Desai, N., Lee, J., Upadhya, R., Chu, Y., Moir, R. D., and Willis, I. M. (2005) Two steps in Maf1-dependent repression of transcription by RNA polymerase III. J. Biol. Chem. 280, 6455-6462 (Pubitemid 40341193)
21. Moir, R. D., Lee, J., Haeusler, R. A., Desai, N., Engelke, D. R., and Willis, I. M. (2006) Protein kinase A regulates RNA polymerase III transcription through the nuclear localization of Maf1. Proc. Natl. Acad. Sci. U.S.A. 103, 15044-15049 (Pubitemid 44583161)
22. Lee, J., Moir, R. D., and Willis, I. M. (2009) Regulation of RNA polymerase III transcription involves SCH9-dependent and SCH9-independent branches of the target of rapamycin (TOR) pathway. J. Biol. Chem. 284, 12604-12608
23. Sarge, K. D., and Park-Sarge, O. K. (2011) SUMO and its role in human diseases. Int. Rev. Cell Mol. Biol. 288, 167-183
24. McDoniels-Silvers, A. L., Nimri, C. F., Stoner, G. D., Lubet, R. A., and You, M. (2002) Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin. Cancer Res. 8, 1127-1138 (Pubitemid 35177366)
25. Han, Y., Huang, C., Sun, X., Xiang, B., Wang, M., Yeh, E. T., Chen, Y., Li, H., Shi, G., Cang, H., Sun, Y., Wang, J., Wang, W., Gao, F., and Yi, J. (2010) SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J. Biol. Chem. 285, 12906-12915
26. Wang, Q., Xia, N., Li, T., Xu, Y., Zou, Y., Zuo, Y., Fan, Q., Bawa-Khalfe, T., Yeh, E. T., and Cheng, J. (2013) SUMO-specific protease 1 promotes prostate cancer progression and metastasis. Oncogene 32, 2493-2498